Klomipramin Viatris (Clomipramine Hydrochloride)

Clomipramine blocks the reuptake of serotonin and norepinephrine, increasing their levels at synaptic sites. This enhanced neurotransmission improves mood regulation and diminishes compulsive thoughts. The drug also antagonizes certain cholinergic, histaminergic and adrenergic receptors, which contributes to its overall pharmacologic profile.

The specific dose of Klomipramin Viatris is determined by the prescribing clinician based on the individual’s diagnosis, severity of symptoms, age, renal and hepatic function, and response to therapy. Dosage adjustments are made according to clinical judgment and patient tolerance.

Safety of clomipramine in pregnancy or while breastfeeding has not been definitively established. Prescribers weigh potential benefits against possible risks to the fetus or infant. Women who are pregnant, planning pregnancy, or nursing should discuss alternatives and risk management with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Clomipramine belongs to the tricyclic class, differing from selective serotonin reuptake inhibitors (SSRIs) and serotonin‑norepinephrine reuptake inhibitors (SNRIs) in its broader receptor activity. It is often more effective for severe OCD but may have a higher incidence of anticholinergic side effects compared with newer agents.

Klomipramin Viatris should be stored at ambient temperature below 25 °C, in the original packaging, protected from moisture and direct light. Keeping the product in a dry, cool place helps maintain its stability and potency throughout its shelf life.

Klomipramin Viatris is taken orally, typically with water. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional. Dosing time (morning or evening) may be adjusted based on the patient’s response and tolerability.

Serious risks include cardiac arrhythmias, seizures, severe hypotension, agranulocytosis, and the potential for serotonin syndrome when combined with other serotonergic drugs. Patients should be monitored for signs of these conditions, especially during treatment initiation or dosage changes.

Klomipramin Viatris is contraindicated in individuals with known hypersensitivity to clomipramine or any tricyclic antidepressant, those currently using monoamine oxidase inhibitors, and patients with recent myocardial infarction or severe cardiac conduction disorders. Clinicians should evaluate each patient’s medical history before prescribing.